Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21933
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Angina, Unstable/*drug therapy/mortality,Enoxaparin/adverse effects/*therapeutic use,Female,Fibrinolytic Agents/*therapeutic use,Heparin, Low-Molecular-Weight/adverse effects/*therapeutic use,Humans,Male,Middle Aged,Myocardial Infarction/*drug therapy/mortality,Prospective Studies,Recurrence
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21933
ISSN: 1097-6744
Link: http://www.ncbi.nlm.nih.gov/pubmed/12891200
http://ac.els-cdn.com/S0002870303001790/1-s2.0-S0002870303001790-main.pdf?_tid=33958277b69f6dad81c2acfd0c5ff2f4&acdnat=1337844990_344fe2529e20f171e0edbd81e91ce029
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Michalis-2003-Enoxaparin versus ti.pdf103.71 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons